University of Tokyo Edge Capital has returned to invest in AI-assisted cardiac diagnosis technology developer Tricog Health.
India-based heart disease diagnostics business Tricog Health has obtained $10.5m in a series B round featuring University of Tokyo Edge Capital (Utec), the institution’s venture capital unit, the Economic Times reported today.
Aflac Ventures, a subdivision of supplemental insurance provider Aflac’s collaborative innovation arm, Aflac Innovation Partners, also participated, as did venture firm Inventus Capital.
The round was also backed by VC fund Blume Ventures, impact investment vehicle TeamFund and startup builder and consultancy Dream Incubator.
Founded…
